WallStreetZenWallStreetZen

NASDAQ: BRKR
Bruker Corp Stock

$85.75-1.83 (-2.09%)
Updated Apr 15, 2024
BRKR Price
$85.75
Fair Value Price
$89.64
Market Cap
$11.81B
52 Week Low
$53.79
52 Week High
$94.86
P/E
29.37x
P/B
8.57x
P/S
3.63x
PEG
N/A
Dividend Yield
0.23%
Revenue
$2.96B
Earnings
$427.20M
Gross Margin
51%
Operating Margin
18.38%
Profit Margin
14.4%
Debt to Equity
2.06
Operating Cash Flow
$350M
Beta
1.1
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BRKR Overview

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BRKR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BRKR ($85.75) is undervalued by 4.34% relative to our estimate of its Fair Value price of $89.64 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BRKR ($85.75) is not significantly undervalued (4.34%) relative to our estimate of its Fair Value price of $89.64 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BRKR ($85.75) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more BRKR due diligence checks available for Premium users.

Be the first to know about important BRKR news, forecast changes, insider trades & much more!

BRKR News

Valuation

BRKR fair value

Fair Value of BRKR stock based on Discounted Cash Flow (DCF)
Price
$85.75
Fair Value
$89.64
Undervalued by
4.34%
BRKR ($85.75) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BRKR ($85.75) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BRKR ($85.75) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BRKR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
29.37x
Industry
29.46x
Market
41.94x
BRKR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BRKR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

BRKR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.57x
Industry
3.71x
BRKR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BRKR's financial health

Profit margin

Revenue
$854.5M
Net Income
$205.5M
Profit Margin
24%
BRKR's Earnings (EBIT) of $544.90M... subscribe to Premium to read more.
Interest Coverage Financials
BRKR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.2B
Liabilities
$2.8B
Debt to equity
2.06
BRKR's short-term assets ($2.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BRKR's short-term assets ($2.16B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BRKR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BRKR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$205.5M
Investing
-$36.8M
Financing
-$59.9M
BRKR's operating cash flow ($350.10M)... subscribe to Premium to read more.
Debt Coverage Financials

BRKR vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
BRKR$11.81B-2.09%29.37x8.57x
PODD$12.16B-0.73%58.76x16.60x
SWAV$12.23B-0.18%81.57x18.29x
SNN$10.44B+0.13%39.40x2.00x
BIO$8.57B-0.01%-13.77x0.98x

Bruker Stock FAQ

What is Bruker's quote symbol?

(NASDAQ: BRKR) Bruker trades on the NASDAQ under the ticker symbol BRKR. Bruker stock quotes can also be displayed as NASDAQ: BRKR.

If you're new to stock investing, here's how to buy Bruker stock.

What is the 52 week high and low for Bruker (NASDAQ: BRKR)?

(NASDAQ: BRKR) Bruker's 52-week high was $94.86, and its 52-week low was $53.79. It is currently -9.6% from its 52-week high and 59.42% from its 52-week low.

How much is Bruker stock worth today?

(NASDAQ: BRKR) Bruker currently has 137,671,143 outstanding shares. With Bruker stock trading at $85.75 per share, the total value of Bruker stock (market capitalization) is $11.81B.

Bruker stock was originally listed at a price of $23.06 in Aug 4, 2000. If you had invested in Bruker stock at $23.06, your return over the last 23 years would have been 271.86%, for an annualized return of 5.88% (not including any dividends or dividend reinvestments).

How much is Bruker's stock price per share?

(NASDAQ: BRKR) Bruker stock price per share is $85.75 today (as of Apr 15, 2024).

What is Bruker's Market Cap?

(NASDAQ: BRKR) Bruker's market cap is $11.81B, as of Apr 16, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bruker's market cap is calculated by multiplying BRKR's current stock price of $85.75 by BRKR's total outstanding shares of 137,671,143.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.